结直肠癌围手术期益生菌治疗的保护机制与临床应用
Protective Mechanism and Clinical Application of Probiotics in Perioperative Treatment of Colorectal Cancer
DOI: 10.12677/jcpm.2025.44425, PDF,    科研立项经费支持
作者: 谭云达*：右江民族医学院研究生学院，广西 百色；刘 通, 王运成#, 龙鹏臣#：百色市人民医院胃肠外科，广西 百色
关键词: 益生菌治疗；结直肠癌；围手术期；肠道微生态；Perioperative Treatment； Colorectal Cancer； Perioperative Period； Intestinal Microecology
摘要: 结直肠癌作为多因素介导的全球性健康负担，其发病率与死亡率呈持续上升趋势。尽管根治性手术仍是治疗核心，但围手术期肠道菌群失调、免疫抑制及代谢紊乱等病理状态显著增加术后并发症风险，并可能影响患者长期生存。近年研究表明，益生菌通过调控肠道微生态平衡，在结直肠癌防治中呈现多效性作用，包括但不限于：1) 重塑肠道菌群结构；2) 保护肠黏膜屏障完整性；3) 调控宿主免疫应答；4) 纠正代谢失衡。本文系统综述益生菌在围手术期的多维度保护机制及其降低术后并发症的临床应用潜力，以期为围手术期管理提供循证依据。
Abstract: Colorectal cancer is a global health burden mediated by multiple factors, and its morbidity and mortality continue to rise. Although radical surgery is still the core of treatment, perioperative pathological conditions such as intestinal flora imbalance, immunosuppression and metabolic disorders significantly increase the risk of postoperative complications and may affect the long-term survival of patients. Recent studies have shown that probiotics play a pleiotropic role in the prevention and treatment of colorectal cancer by regulating intestinal microecological balance, including but not limited to: 1) Remodeling the structure of intestinal flora; 2) Protect the integrity of intestinal mucosal barrier; 3) Regulating host immune response; 4) Correct metabolic imbalance. This article systematically reviews the multi-dimensional protection mechanism of probiotics in perioperative period and its clinical application potential in reducing postoperative complications, in order to provide evidence-based basis for perioperative management.
文章引用：谭云达, 刘通, 王运成, 龙鹏臣. 结直肠癌围手术期益生菌治疗的保护机制与临床应用[J]. 临床个性化医学, 2025, 4(4): 124-131. https://doi.org/10.12677/jcpm.2025.44425

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Bartolini, I., Risaliti, M., Ringressi, M.N., Melli, F., Nannini, G., Amedei, A., et al. (2020) Role of Gut Microbiota-Immunity Axis in Patients Undergoing Surgery for Colorectal Cancer: Focus on Short and Long-Term Outcomes. World Journal of Gastroenterology, 26, 2498-2513. [Google Scholar] [CrossRef] [PubMed]
[3] Dickson, R.P. (2016) The Microbiome and Critical Illness. The Lancet Respiratory Medicine, 4, 59-72. [Google Scholar] [CrossRef] [PubMed]
[4] Sepehr, A., Miri, S.T., Aghamohammad, S., Rahimirad, N., Milani, M., Pourshafie, M., et al. (2024) Health Benefits, Antimicrobial Activities, and Potential Applications of Probiotics: A Review. Medicine, 103, e32412. [Google Scholar] [CrossRef] [PubMed]
[5] Yu, L., Xiao, M., Tian, F., Chen, W. and Zhai, Q. (2024) Glycan Utilization Properties Govern the Cross-Feeding Network in Gut Microbiota: A Focus on Bifidobacteria. Science Bulletin, 69, 299-302. [Google Scholar] [CrossRef] [PubMed]
[6] Serek, P. and Oleksy-Wawrzyniak, M. (2021) The Effect of Bacterial Infections, Probiotics and Zonulin on Intestinal Barrier Integrity. International Journal of Molecular Sciences, 22, Article 11359. [Google Scholar] [CrossRef] [PubMed]
[7] 于健春, 康维明. 外科手术创伤对肠黏膜屏障的影响[J]. 中国医刊, 2008(10): 19-22.
[8] Zhao, Y., Yang, H., Wu, P., Yang, S., Xue, W., Xu, B., et al. (2024) Akkermansia muciniphila: A Promising Probiotic against Inflammation and Metabolic Disorders. Virulence, 15, Article 2375555. [Google Scholar] [CrossRef] [PubMed]
[9] Bock, P.M., Martins, A.F. and Schaan, B.D. (2024) Understanding How Pre-and Probiotics Affect the Gut Microbiome and Metabolic Health. American Journal of Physiology-Endocrinology and Metabolism, 327, E89-E102. [Google Scholar] [CrossRef] [PubMed]
[10] Pais, P., Almeida, V., Yılmaz, M. and Teixeira, M.C. (2020) Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? Journal of Fungi, 6, Article 78. [Google Scholar] [CrossRef] [PubMed]
[11] Thoda, C. and Touraki, M. (2023) Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment. Microorganisms, 11, Article 1898. [Google Scholar] [CrossRef] [PubMed]
[12] Bezu, L., Akçal Öksüz, D., Bell, M., Buggy, D., Diaz-Cambronero, O., Enlund, M., et al. (2024) Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review. Cancers, 16, Article 2304. [Google Scholar] [CrossRef] [PubMed]
[13] Pitsillides, L., Pellino, G., Tekkis, P. and Kontovounisios, C. (2021) The Effect of Perioperative Administration of Probiotics on Colorectal Cancer Surgery Outcomes. Nutrients, 13, Article 1451. [Google Scholar] [CrossRef] [PubMed]
[14] Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E. and Rotondo, J.C. (2023) Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells, 12, Article 184. [Google Scholar] [CrossRef] [PubMed]
[15] Yue, F., Zeng, X., Wang, Y., Fang, Y., Yue, M., Zhao, X., et al. (2024) Bifidobacterium Longum SX-1326 Ameliorates Gastrointestinal Toxicity after Irinotecan Chemotherapy via Modulating the P53 Signaling Pathway and Brain-Gut Axis. BMC Microbiology, 24, Article No. 8. [Google Scholar] [CrossRef] [PubMed]
[16] Campbell, C., Kandalgaonkar, M.R., Golonka, R.M., Yeoh, B.S., Vijay-Kumar, M. and Saha, P. (2023) Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. Biomedicines, 11, Article 294. [Google Scholar] [CrossRef] [PubMed]
[17] Chandrasekaran, P., Weiskirchen, S. and Weiskirchen, R. (2024) Effects of Probiotics on Gut Microbiota: An Overview. International Journal of Molecular Sciences, 25, Article 6022. [Google Scholar] [CrossRef] [PubMed]
[18] Galdeano, C.M., Cazorla, S.I., Dumit, J.M.L., et al. (2019) Beneficial Effects of Probiotic Consumption on the Immune System. Annals of Nutrition and Metabolism, 74, 115-124.
[19] Hu, W.H., Cajas-Monson, L.C., Eisenstein, S., et al. (2015) Preoperative Malnutrition Assessments as Predictors of Postoperative Mortality and Morbidity in Colorectal Cancer: An Analysis of ACS-NSQIP. Nutrition Journal, 14, Article No. 91. [Google Scholar] [CrossRef] [PubMed]
[20] Gupta, A., Gupta, E., Hilsden, R., Hawel, J.D., Elnahas, A.I., Schlachta, C.M., et al. (2021) Preoperative Malnutrition in Patients with Colorectal Cancer. Canadian Journal of Surgery, 64, E621-E629. [Google Scholar] [CrossRef] [PubMed]
[21] Lu, S., Chen, Z., Peng, R., Zhang, Q., Wang, Y., Li, X., et al. (2023) Prognostic Effect of Preoperative Controlling Nutritional Status Score in Patients with Locally Advanced Rectal Cancer: A Two-Center, Retrospective Study. Nutrition, 112, Article 112078. [Google Scholar] [CrossRef] [PubMed]
[22] Bermúdez-Humarán, L.G., Chassaing, B. and Langella, P. (2024) Exploring the Interaction and Impact of Probiotic and Commensal Bacteria on Vitamins, Minerals and Short Chain Fatty Acids Metabolism. Microbial Cell Factories, 23, Article No. 172. [Google Scholar] [CrossRef] [PubMed]
[23] Mann, E.R., Lam, Y.K. and Uhlig, H.H. (2024) Short-Chain Fatty Acids: Linking Diet, the Microbiome and Immunity. Nature Reviews Immunology, 24, 577-595. [Google Scholar] [CrossRef] [PubMed]
[24] Stoeva, M.K., Garcia-So, J., Justice, N., Myers, J., Tyagi, S., Nemchek, M., et al. (2021) Butyrate-Producing Human Gut Symbiont, Clostridium butyricum, and Its Role in Health and Disease. Gut Microbes, 13, Article 1907272. [Google Scholar] [CrossRef] [PubMed]
[25] Lawler, J., Choynowski, M., Bailey, K., Bucholc, M., Johnston, A. and Sugrue, M. (2020) Meta-Analysis of the Impact of Postoperative Infective Complications on Oncological Outcomes in Colorectal Cancer Surgery. BJS Open, 4, 737-747. [Google Scholar] [CrossRef] [PubMed]
[26] Chen, Y., Qi, A., Teng, D., Li, S., Yan, Y., Hu, S., et al. (2022) Probiotics and Synbiotics for Preventing Postoperative Infectious Complications in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Techniques in Coloproctology, 26, 425-436. [Google Scholar] [CrossRef] [PubMed]
[27] Tzikos, G., Tsalkatidou, D., Stavrou, G., Thoma, G., Chorti, A., Tsilika, M., et al. (2022) A Four-Probiotic Regime to Reduce Surgical Site Infections in Multi-Trauma Patients. Nutrients, 14, Article 2620. [Google Scholar] [CrossRef] [PubMed]
[28] 董明, 唐景彤, 姚宏伟. 中国结直肠癌手术病人营养治疗指南(2025版) [J]. 中国实用外科杂志, 2025, 45(2): 137-148.
[29] Kotzampassi, K., Stavrou, G., Damoraki, G., Georgitsi, M., Basdanis, G., Tsaousi, G., et al. (2015) A Four-Probiotics Regimen Reduces Postoperative Complications after Colorectal Surgery: A Randomized, Double-Blind, Placebo-Controlled Study. World Journal of Surgery, 39, 2776-2783. [Google Scholar] [CrossRef] [PubMed]
[30] Marcellinaro, R., Grieco, M., Spoletini, D., Troiano, R., Avella, P., Brachini, G., et al. (2023) How to Reduce the Colorectal Anastomotic Leakage? The Miracle Protocol Experience in a Cohort in a Single High-Volume Centre. Updates in Surgery, 75, 1559-1567. [Google Scholar] [CrossRef] [PubMed]
[31] Bajramagic, S., Hodzic, E., Mulabdic, A., Holjan, S., Smajlovic, S. and Rovcanin, A. (2019) Usage of Probiotics and Its Clinical Significance at Surgically Treated Patients Sufferig from Colorectal Carcinoma. Medical Archives, 73, 316-320. [Google Scholar] [CrossRef] [PubMed]
[32] Moreira, M.M., Carriço, M., Capelas, M.L., Pimenta, N., Santos, T., Ganhão-Arranhado, S., et al. (2024) The Impact of Pre-, Pro-and Synbiotics Supplementation in Colorectal Cancer Treatment: A Systematic Review. Frontiers in Oncology, 14, Article 1395966. [Google Scholar] [CrossRef] [PubMed]
[33] Guarner, F., Sanders, M.E., Szajewska, H., Cohen, H., Eliakim, R., et al. (2024) World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics. Journal of Clinical Gastroenterology, 58, 533-553. [Google Scholar] [CrossRef] [PubMed]
[34] 陈思娇, 邬文君, 郑雅文. 术前口服复合益生菌对结直肠癌根治术后感染性并发症的预防作用[J]. 中国药师, 2023, 26(10): 119-124.
[35] 刘淦, 田玉龙, 张兴起, 等. 围手术期益生菌治疗对新辅助化疗联合胃癌根治术后近期临床结局影响的前瞻性研究[J]. 中华消化外科杂志, 2022, 21(3): 375-384.
[36] Kurdi, M., Bajwa, S.J.S., Sharma, R. and Choudhary, R. (2024) Gut Microbiota and Probiotics in Perioperative Management: A Narrative Review. Cureus, 16, e68404. [Google Scholar] [CrossRef] [PubMed]
[37] Yadav, M.K., Kumari, I., Singh, B., Sharma, K.K. and Tiwari, S.K. (2022) Probiotics, Prebiotics and Synbiotics: Safe Options for Next-Generation Therapeutics. Applied Microbiology and Biotechnology, 106, 505-521. [Google Scholar] [CrossRef] [PubMed]
[38] Katkowska, M., Garbacz, K. and Kusiak, A. (2021) Probiotics: Should All Patients Take Them? Microorganisms, 9, Article 2620. [Google Scholar] [CrossRef] [PubMed]
[39] Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., et al. (2018) Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features. Cell, 174, 1388-1405. [Google Scholar] [CrossRef] [PubMed]
[40] Zuo, Z. and Zhao, F. (2023) Gut Microbiota-Targeted Interventions: From Conventional Approaches to Genetic Engineering. Science Bulletin, 68, 1231-1234. [Google Scholar] [CrossRef] [PubMed]
[41] Tóth, A.G., Judge, M.F., Nagy, S.Á., Papp, M. and Solymosi, N. (2023) A Survey on Antimicrobial Resistance Genes of Frequently Used Probiotic Bacteria, 1901 to 2022. Eurosurveillance, 28, Article 2200272. [Google Scholar] [CrossRef] [PubMed]
[42] Zhang, J. and Knight, R. (2023) Genomic Mutations within the Host Microbiome: Adaptive Evolution or Purifying Selection. Engineering, 20, 96-102. [Google Scholar] [CrossRef] 
[43] Szajewska, H. and Vinderola, G. (2024) Current Regulatory Issues for the Use of Probiotics. Advances in Experimental Medicine and Biology, 1449, 187-193. [Google Scholar] [CrossRef] [PubMed]